Galy
Galy creates cotton in a laboratory from cells utilizing a proprietary method instead of plants that are good in quality, and cheaper than natural cotton, enabling clothing brands and textile industries with raw material that has a lower environmental impact.
$33M
Latest Funding
Series B
Latest Funding Stage
2024-09-04
Funding Date
80
Employees
United States
Location
San Francisco, California
City & State
Sales-Ready Summary
Galy recently raised a $33M Series B and utilizes a tech stack that includes Google Analytics and various JavaScript frameworks and libraries, suggesting a potential need for advanced analytics and development tools. Given their recent funding, reaching out to their HR department could be beneficial for vendors offering employee benefits or HR management solutions.
Key Contacts
Open Positions
View Careers PageHiring For
Similar Startups
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that focuses on developing innovative technologies for drug discovery. The company utilizes advanced live-cell resolution microscopy and engineering to identify and create new therapeutic candidates. Eikon Therapeutics aims to enhance the understanding of biological processes at a cellular level,supporting targeted treatment development.
Arsenale Bioyards
Arsenale is transforming biomanufacturing with a proprietary end-to-end platform that integrates advanced hardware, AI-driven software, and precision fermentation. Designed to bridge the gap from lab-scale innovation to industrial-scale production, Arsenale enables industries like food, chemicals, and materials to seamlessly develop and scalebio-based alternatives to petrochemicals and animal-derived products.
EvidenceHunt
EvidenceHunt is an AI-powered research assistant developed by medical professionals for healthcare research. Our focus is on delivering tools that streamline gathering and analyzing clinical evidence. With features like AI Chat for interactive queries and comprehensive Direct Search options, EvidenceHunt allows precise data retrieval andanalysis.
Avitia
Avitia improves cancer treatment via advanced molecular testing solutions. Avitia offer testing tools for use on-site, bioinformatics driven by AI, and actionable insights aimed at enhancing patient outcomes. Avitia offerings comprise pre-prepared NGS panels, simplified reporting mechanisms, and cooperative diagnostic platforms.